Literature DB >> 8824572

Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity.

J R Currier1, H Deulofeut, K S Barron, P J Kehn, M A Robinson.   

Abstract

The third complementarity-determining region (CDR3) is the only nongermline-encoded hypervariable region of the T cell receptor beta (TCRB) chain, and it is the region that has been predicted to confer fine specificity of the TCR for peptide-MHC complexes. For this reason analysis of TCRB CDR3 heterogeneity may provide insight into immune mechanisms operative in infectious and autoimmune diseases. PBMC stimulated with either mitogen (PHA), superantigen (TSST-1), or nominal antigen (tetanus toxoid) have been compared with unstimulated PBMC using a two-dimensional approach. Analysis of the expressed TCRBV gene repertoire CDR3 length profile coupled with SSCP methodology enabled the discrimination of sequences with the same CDR3 length. For both freshly isolated and PHA stimulated PBMC, a normally distributed spectrum of CDR3 lengths (five or more products) was observed. These products differed by 3 bp (1 amino acid) due to the strict requirement for in-frame rearrangements in the CDR3 region of TCR. By contrast, tetanus toxoid stimulated PBMC had restricted profiles for most TCRBV families after as few as 7 days of incubation. The oligoclonal nature of samples showing CDR3 length restriction was revealed by SSCP analysis and confirmed by sequence determination. Superantigen stimulation resulted in unique patterns of diversity, which included polyclonal expansion of specific TCRBV families as well as oligoclonal expansion of most other TCRBV families. These data reveal complex yet distinct patterns of TCR diversity in response to different T cell activation stimuli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824572     DOI: 10.1016/0198-8859(96)00076-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

1.  MaGiK method of T-Cell receptor repertoire analysis.

Authors:  M Scott Killian; Jose Matud; Roger Detels; Janis V Giorgi; Beth D Jamieson
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.

Authors:  Richard C Wu; Shujuan Liu; Jessica A Chacon; Sheng Wu; Yufeng Li; Pariya Sukhumalchandra; James L Murray; Jeffrey J Molldrem; Patrick Hwu; Hanspeter Pircher; Gregory Lizée; Laszlo G Radvanyi
Journal:  Clin Cancer Res       Date:  2012-02-03       Impact factor: 12.531

3.  A variable immunoreceptor in a subpopulation of human neutrophils.

Authors:  Kerstin Puellmann; Wolfgang E Kaminski; Mandy Vogel; C Thomas Nebe; Josef Schroeder; Hans Wolf; Alexander W Beham
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

4.  T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.

Authors:  H Wu; G Y Zhang; J F Knight
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

5.  T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.

Authors:  P F Fogarty; M E Rick; W Zeng; A M Risitano; C E Dunbar; J B Bussel
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  Generation of T lineage cells from human embryonic stem cells in a feeder free system.

Authors:  Zoran Galić; Scott G Kitchen; Aparna Subramanian; Greg Bristol; Matthew D Marsden; Arumugam Balamurugan; Amelia Kacena; Otto Yang; Jerome A Zack
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

7.  Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.

Authors:  Sara Yousef; Johanna Heise; Nesrine Lajmi; Katrin Bartels; Nicolaus Kröger; Tim Luetkens; Djordje Atanackovic
Journal:  J Transl Med       Date:  2015-06-20       Impact factor: 5.531

8.  Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis.

Authors:  Francesco Ria; Romina Penitente; Maria De Santis; Chiara Nicolò; Gabriele Di Sante; Massimiliano Orsini; Dario Arzani; Andrea Fattorossi; Alessandra Battaglia; Gian Franco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2008-11-17       Impact factor: 5.156

9.  Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.

Authors:  J Lori Blanchfield; Shayla K Shorter; Brian D Evavold
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

10.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.